# A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers

> **NCT01643889** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 44 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Treatment A (domperidone 10 mg)
- **DRUG:** Treatment B (domperidone 20 mg)
- **DRUG:** Treatment C (placebo)
- **DRUG:** Treatment D (moxifloxacin)

## Key facts

- **NCT ID:** NCT01643889
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2013-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01643889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01643889, "A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01643889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*